"Als hochmodernes Zentrum widmen wir uns ausschließlich der Durchführung von Medikamenten- zulassungsstudien nach internationalen Standards. Unabhängig von Ihrem Versicherungsstatus bieten wir Ihnen einen unmittelbaren Zugang zu den aktuellen und innovativsten Therapiemöglichkeiten. Bei uns können Sie vom medizinischen Fortschritt profitieren und erhalten für Ihr spezifisches Erkrankungsprofil nach umfassender ärztlicher Analyse die neueste Therapiekonzeption. Termine während der Öffnungszeiten und nach Vereinbarung."

During the past decade, SIBAmed Studienzentrum GmbH & Co.KG conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 2 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "SIBAmed Studienzentrum GmbH & Co.KG" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Pfizer" with 2 trials sponsored, "Bavarian Nordic" with 1 trials sponsored, "GWT-TUD GmbH" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "SIBAmed Studienzentrum GmbH & Co.KG" #1 collaborator was "Dermira, Inc." with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "SIBAmed Studienzentrum GmbH & Co.KG" are "Dermatitis, Atopic" (2 trials), "Atopic Dermatitis" (1 trials), "Clostridium Difficile Infection" (1 trials), "Cytomegalovirus Infection" (1 trials) and "Dermatitis" (1 trials). Many other conditions were trialed in "SIBAmed Studienzentrum GmbH & Co.KG" in a lesser frequency.

Most popular intervention types in "SIBAmed Studienzentrum GmbH & Co.KG" are "Biological" (6 trials), "Drug" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ad26.RSV.preF-based Vaccine" (1 trials), "Cigarette smoking" (1 trials), "Clostridium difficile vaccine" (1 trials) and "Dulaglutide" (1 trials). Other intervention names were less common.

The vast majority of trials in "SIBAmed Studienzentrum GmbH & Co.KG" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "SIBAmed Studienzentrum GmbH & Co.KG". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in SIBAmed Studienzentrum GmbH & Co.KG, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SIBAmed Studienzentrum GmbH & Co.KG, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".